08:06 AM EDT, 06/23/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) said Monday that its phase 2b trial evaluating CD388, its long-acting antiviral for seasonal influenza prevention, met its primary and secondary endpoints. The study showed that a single dose of CD388 provided 76.1% protection at 450 mg, 61.3% at 300 mg, and 57.7% at 150 mg against symptomatic...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

08:06 AM EDT, 06/23/2025 (MT Newswires) -- Leap Therapeutics ( LPTX ) said Monday its phase 2 sirexatamab colorectal cancer study demonstrated significant benefits in patients with high levels of DKK1, no prior exposure to anti-VEGF therapy, or liver metastasis. The study assessed sirexatamab in combination with bevacizumab and chemotherapy, compared to bevacizumab and chemotherapy, in patients with advanced microsatellite...

June 23 (Reuters) - Anthony Pompliano's ProCap Financial will go public through a merger with blank-check vehicle Columbus Circle Capital Corp, the American entrepreneur said on Monday. (Reporting by Arasu Kannagi Basil in Bengaluru) ...